Blog

What Treatment Options are Available for Blood Cancer Patients?

Here is another article dedicated for Blood Cancer Awareness Month. In this blog post, we will take a closer look at the factors that decide which treatment option to consider for blood cancer and the treatment options available for blood cancer patients.

There are a range of factors that will determine the blood cancer treatment regimes that a person will be placed on. These factors include:

Read More

Awareness Month: 7 Facts about Blood Cancer You Should Know

September is Blood Cancer Awareness Month! To commemorate this important event, we are going to share with you a series of articles talking about blood cancer. In these articles, we will provide you some background information on blood cancer as well as explain the important role of cord blood stem cells in potentially treating blood cancers.

On this first article, we'll start with some of the facts you need to know about blood cancer.

Read More

Making Stem Cell Transplants Safer and More Effective

Hematopoietic stem cell transplants have been used to saved the lives of many thousands of cancer patients over the past few decades. They have been an absolute game changer in terms of survival rates.

However, before receiving a stem cell transfusion, cancer patients need to be treated with high dose of chemotherapy and radiation. This treatment kills the mutated cells which are causing the patient’s cancer, in a process known as ‘conditioning’.

Read More

Placental-Derived Stem Cell Therapy for Premature Babies with Intestinal Disease

Premature babies have a very difficult start to life. Their bodies are not adequately prepared for life outside of the womb and they are vulnerable to a range of illnesses.

One of the most common illnesses suffered by premature babies is called necrotising enterocolitis. It is a life-threatening disease of the bowels, which affects about 10% of all pre-term babies.

Read More

Umbilical Cord Stem Cells Hold Potential in Pulmonary Fibrosis Treatment

Pulmonary Fibrosis is a potentially life-threatening condition caused by scarring of the lungs. It leads to a variety of dangerous complications including lung cancer, pulmonary hypertensions, pneumothorax, and respiratory failure.

A new study suggests that pulmonary fibrosis could be treated with umbilical cord stem cells. The study, titled “Extracellular vesicles derived from umbilical cord mesenchymal stromal cells alleviate pulmonary fibrosis by means of transforming growth factor-β signaling inhibition” was recently published in Stem Cell Research & Therapy.

Read More

Using Cord Blood MSCs to treat BPD in Premature Infants Shows Promising Results

The results of a Phase II clinical trial investigating the use of umbilical cord blood mesenchymal stem cells (MSCs) to treat bronchopulmonary dysplasia (BPD) have recently been published.

Bronchopulmonary dysplasia is a lung disease which affects newborn babies. It is particularly common in premature infants and babies with a low birth weight. Researchers believe that the condition is exacerbated by or caused by prolonged mechanical ventilation.

Read More

Using Placental Stem Cells to Treat In-Utero Patients with Spina Bifida

A research team from UC Davis Health has been working in collaboration with the Fetal Surgery Department at the medical campus in recent months. They are working together to launch a groundbreaking clinical trial which will treat in-utero patients suffering from a birth defect called spina bifida using placental stem cells.

Read More

Stem Cell Therapy, A New Multiple Sclerosis Breakthrough in 2021?

Multiple sclerosis (MS) is a devastating neurological disease that affects millions of people worldwide. It occurs when the protective layer that surround the brain’s nerve cells break down, interfering with the electrical impulses that travel along each nerve.

Read More

Umbilical Cord Stem Cells for Severely Ill COVID19 Patients

According to the latest statistics, only 60% of the patients with COVID-19 admitted to an intensive care unit will survive. The other 40% succumb to the virus, leaving behind devastated families and friends.

A group of Canadian researchers believes that umbilical cord blood stem cells could greatly improve the chances that these severely ill patients will survive.

Read More

Umbilical Cord Stem Cells Eased Dystrophic Epidermolysis Bullosa (RDEB) Symptoms

Researchers have already discovered that the mesenchymal stem cells (MSCs) contained within umbilical cord blood have remarkable regenerative properties. They are capable of repairing tissue, reducing inflammation, moderating the immune system and much more.

Read More

Recent Posts